Barbara Kure Klein
38Patents
13h-index
28Co-inventors
77Inventor score
Filing activity: Jun 21, 1993 → Jun 9, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5997860A | Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines | Chemistry; Metallurgy | 60 | Expired |
| US5858347A | Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors | Emerging Cross-Sectional Technologies | 47 | Expired |
| US6541678B2 | Immunostimulating coating for surgical devices | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6030812A | Fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors | Chemistry; Metallurgy | 30 | Expired |
| US6440407B1 | Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7348021B2 | Immunostimulating coating for surgical devices | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5772992A | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors | Chemistry; Metallurgy | 21 | Expired |
| US6361977B1 | Methods of using multivariant IL-3 hematopoiesis fusion protein | Chemistry; Metallurgy | 19 | Expired |
| US5980918A | .beta.-D-glucan topical composition | Human Necessities | 17 | Expired |
| US5604116A | Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6100070A | G-CSF receptor agonists | Human Necessities | 15 | Expired |
| US5738849A | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6022535A | Treatment of hematopoietic disorders with fusion proteins comprising multiply mutated interleukin-3 (IL-3) polypeptides and second growth factors | Chemistry; Metallurgy | 13 | Expired |
| US5677149A | Interleukin-3 (IL-3) mutant polypeptides and their recombinant production | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6066318A | Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors | Chemistry; Metallurgy | 11 | Expired |
| US6074639A | Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins | Emerging Cross-Sectional Technologies | 11 | Expired |
| US6057133A | Multivariant human IL-3 fusion proteins and their recombinant production | Chemistry; Metallurgy | 11 | Expired |
| US6060047A | Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production | Human Necessities | 9 | Expired |
| US6051217A | Therapeutic uses of interleukin-3 (IL-3) multiple mutation polypeptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6168799A | .beta.-D-glucan topical composition | Human Necessities | 8 | Expired |
| US5501962A | Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same | Human Necessities | 8 | Expired |
| US6132991A | Human interleukin-3 (IL-3) variant fusion proteins | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6153183A | Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production | Human Necessities | 8 | Expired |
| US6093395A | Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production | Human Necessities | 8 | Expired |
| US5543141A | Therapeutic methods using interleukin-3 (IL-3) human/murine hybrid polypeptides | Human Necessities | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.